Inhibition of miR-33a-5p in Macrophage-like Cells In Vitro Promotes apoAI-Mediated Cholesterol Efflux
Pathophysiology · 28.02.2024 · 31 (1) · 117-126
DOI: 10.3390/pathophysiology31010009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathophysiology, online erschienen am 28.02.2024. Verfasst von Olanrewaju Oladosu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Atherosclerosis is caused by cholesterol accumulation within arteries. The intima is where atherosclerotic plaque accumulates and where lipid-laden foam cells reside. Intimal foam cells comprise of both monocyte-derived macrophages and macrophage-like cells (MLC) of vascular smooth muscle cell (VSMC) origin. Foam cells can remove cholesterol via apoAI-mediated cholesterol efflux and this process is regulated by the transporter ABCA1. The microRNA miR-33a-5p is thought to be atherogenic via silencing ABCA1 which promotes cholesterol retention and data has shown inhibiting miR-33a-5p in macrophages may be atheroprotective via enhancing apoAI-mediated cholesterol efflux. However, it is not entirely elucidated whether precisely inhibiting miR-33a-5p in MLC also increases ABCA1-dependent cholesterol efflux. Therefore, the purpose of this work is to test the hypothesis that inhibition of miR-33a-5p in cultured MLC enhances apoAI-mediated cholesterol efflux. In our study, we utilized the VSMC line MOVAS cells in our experiments, and cholesterol-loaded MOVAS cells to convert this cell line into MLC. Inhibition of miR-33a-5p was accomplished by transducing cells with a lentivirus that expresses an antagomiR directed at miR-33a-5p. Expression of miR-33a-5p was analyzed by qRT-PCR, ABCA1 protein expression was assessed via immunoblotting, and apoAI-mediated cholesterol efflux was measured using cholesterol efflux assays. In our results, we demonstrated that lentiviral vector-mediated knockdown of miR-33a-5p resulted in decreasing expression of this microRNA in cultured MLC. Moreover, reduction of miR-33a-5p in cultured MLC resulted in de-repression of ABCA1 expression, which caused ABCA1 protein upregulation in cultured MLC. Additionally, this increase in ABCA1 protein expression resulted in enhancing ABCA1-dependent cholesterol efflux through increasing apoAI-mediated cholesterol efflux in cultured MLC. From these findings, we conclude that inhibiting miR-33a-5p in MLC may protect against atherosclerosis by promoting ABCA1-dependent cholesterol efflux.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA.
- Clemson Light Imaging Facility, Clemson University, Clemson, SC 29634, USA.
ORCID-Profile: Rhonda R Powell, Alexis Stamatikos
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NIH/NHLBI Academic Research Enhancement Award
- NIH Eukaryotic Pathogens Innovation Center (EPIC) Centers of Biomedical Research Excellence (COBRE)
- NIH SC BioCRAFT COBRE
- Clemson University Division of Research
Zitieren
APA
Oladosu, O., Chin, E., Barksdale, C., Powell, R. R., Bruce, T., & Stamatikos, A. (2024). Inhibition of miR-33a-5p in Macrophage-like Cells In Vitro Promotes apoAI-Mediated Cholesterol Efflux. Pathophysiology, 31(1), 117-126. https://doi.org/10.3390/pathophysiology31010009
Vancouver
Oladosu O, Chin E, Barksdale C, Powell RR, Bruce T, Stamatikos A. Inhibition of miR-33a-5p in Macrophage-like Cells In Vitro Promotes apoAI-Mediated Cholesterol Efflux. Pathophysiology. 2024;31(1):117-126. doi:10.3390/pathophysiology31010009
BibTeX
@article{Oladosu2024,
author = {Oladosu, Olanrewaju and Chin, Emma and Barksdale, Christian and Powell, Rhonda R and Bruce, Terri and Stamatikos, Alexis},
title = {Inhibition of miR-33a-5p in Macrophage-like Cells In Vitro Promotes apoAI-Mediated Cholesterol Efflux},
journal = {Pathophysiology},
year = {2024},
volume = {31},
number = {1},
pages = {117--126},
doi = {10.3390/pathophysiology31010009}
}
EUVIMED